Clinical Trial Update: Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Ongoing Phase 1 safety/efficacy trial of CID-078 in patients with advanced/metastatic solid tumors; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Neuroendocrine Carcinoma
• Neuroendocrine Tumors
• Triple-negative Breast Cancer

Drugs mentioned

• CID-078

Snippet

Sponsor: Circle Pharma | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING